Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

IMPORTANCE: Weight loss improves cardiometabolic risk factors in people with overweight or obesity. Intensive lifestyle intervention and pharmacotherapy are the most effective noninvasive weight loss approaches. OBJECTIVE: To compare the effects of once-weekly subcutaneous semaglutide, 2.4 mg vs pla...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA
Main Authors: Wadden, Thomas A., Bailey, Timothy S., Billings, Liana K., Davies, Melanie, Frias, Juan P., Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M., Rubino, Domenica M., Skovgaard, Dorthe, Wallenstein, Signe O. R., Garvey, W. Timothy
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2021
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905697/
https://ncbi.nlm.nih.gov/pubmed/33625476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.1831
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker